Clinical Trials Directory

Trials / Completed

CompletedNCT00194168

Ectopic Pregnancy Biomarkers

Serum Bank for Assessment of Markers of Ectopic Pregnancy

Status
Completed
Phase
Study type
Observational
Enrollment
1,306 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

In an attempt to simplify the diagnosis of ectopic pregnancy, the researchers will investigate the presence of specific molecular markers of ectopic pregnancy. The quantification of these (and other proteins) will be performed using the Ciphergen Protein Chip system where serum is sampled with a high-throughput system. The patterns of these peaks will be compared for those with a diagnosis of ectopic pregnancy and normal pregnancy. Later goals of the research will be to identify the actual proteins that correspond to the peaks which discriminate between the two clinical entitles. The goal is to identify a unique protein pattern or protein peak to distinguish a normal intrauterine pregnancy from that of an ectopic implanted gestation.

Conditions

Timeline

Start date
2000-06-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2005-09-19
Last updated
2016-08-16

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00194168. Inclusion in this directory is not an endorsement.

Ectopic Pregnancy Biomarkers (NCT00194168) · Clinical Trials Directory